Roche To Submit Breast Cancer Drug Pertuzumab In USA And Europe Later This Year
7/15/2011
Roche Holding announced it will submit its breast cancer drug Pertuzumab towards the end of 2011 for approval in the USA and Europe after Genentech (a Roche company) said its Phase III clinical evaluation of the Pertuzumab and trastuzumab (Cleopatra) trial met its main goal (primary endpoint)...
Researchers Developing Synthetic Material To Revitalize Damaged Vocal Cords
7/15/2011
In 1997, the actress and singer Julie Andrews lost her singing voice following surgery to remove noncancerous lesions from her vocal cords. She came to Steven Zeitels, a professor of laryngeal surgery at Harvard Medical School, for help. Zeitels was already starting to develop a new type of material that could be implanted into scarred vocal cords to restore their normal function...
White Paper On IMRT Safety Published By ASTRO
7/15/2011
As part of the Target Safely initiative, the American Society for Radiation Oncology (ASTRO) has developed a white paper, the first of a series of such papers, on the safe use of integrating intensity modulated radiation therapy (IMRT) into the radiation oncology clinic...
Camels At The Root Of Potential New Cancer Gene Therapy
7/15/2011
Nanobodies produced by camels have unique properties, which can be used in future drug development. New research published in the Journal of Controlled Release confirms that nanobodies can help scientists in the fight against cancer. Members of the camelid family have particular heavy-chain antibodies in their blood known as nanobodies, that may serve as therapeutic proteins...
The results of a study published in the July 13 issue of JAMA have revealed that throughout adulthood considerable changes occur in a patient's family history related to colorectal, breast, and prostate cancer between the ages of 30 and 50 years. This calls for more frequent cancer screening with the patient's family history of cancer being reviewed every 5 to 10 years...
Identification Of Protein May Help Diagnose And Treat Lymphoma In Humans And Canines
7/15/2011
A protein that appears to play a key role in the formation of lymphoma and other tumors by inhibiting a tumor-suppressing gene has been identified by a team of veterinary and human medicine researchers at the University of California, Davis. The researchers suggest that the newly identified protein may be a potential target for diagnosing and treating lymphoma in humans and animals...
The Complexity Of Glue Molecule's Role In Cancer Revealed By Stem Cell Study
7/15/2011
A protein molecule that 'glues' cells together and so has a key role in cancer is also responsible for many other important functions of cells, a new study has found. University of Manchester scientists say their unexpected findings are important because they could lead to a better understanding of why some cancer cells are difficult to eradicate in patients and lead to new cancer treatments...
Altered Metabolic Pathway In ER-Negative Breast Cancer May Provide New Target for Treatment
7/15/2011
Researchers in the emerging field of cancer metabolism have found an altered metabolic pathway in ER-negative breast cancers that could open the door to new treatments for a type of breast cancer that currently has a poor prognosis and few cancer prevention and treatment options. They write about their discovery in a paper published early online this week in the journal Nature...
Early-Stage Melanoma Tumors Contain Clues To Metastatic Potential
7/15/2011
Wanderlust in a person can be admirable or romantic. In a cancerous tumor, it may be lethal. Most deaths from cancer result from tumor cells that have strayed from their original location to insinuate their way into distant tissues...
YERVOY™ (Ipilimumab) Approved For The Treatment Of Previously-Treated Advanced Melanoma In The EU
7/15/2011
Bristol-Myers Squibb announced that the European Commission has approved YERVOY™ (ipilimumab) for the treatment of adult patients with previously-treated advanced melanoma...